PAROLARO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 15.864
EU - Europa 8.583
AS - Asia 4.956
SA - Sud America 615
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
Totale 30.122
Nazione #
US - Stati Uniti d'America 15.700
IT - Italia 4.230
SG - Singapore 1.734
UA - Ucraina 1.457
CN - Cina 956
SE - Svezia 772
VN - Vietnam 744
TR - Turchia 631
HK - Hong Kong 549
BR - Brasile 521
FI - Finlandia 411
DE - Germania 361
IE - Irlanda 356
GB - Regno Unito 285
FR - Francia 282
RU - Federazione Russa 192
IN - India 86
CA - Canada 85
MX - Messico 58
JP - Giappone 57
BD - Bangladesh 48
NL - Olanda 45
PL - Polonia 33
BE - Belgio 30
ZA - Sudafrica 29
AR - Argentina 28
ES - Italia 26
CZ - Repubblica Ceca 24
IQ - Iraq 23
PK - Pakistan 17
AT - Austria 16
CO - Colombia 15
EU - Europa 15
NG - Nigeria 14
MY - Malesia 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
MA - Marocco 10
EC - Ecuador 9
IL - Israele 9
JO - Giordania 9
LT - Lituania 9
UZ - Uzbekistan 9
MD - Moldavia 8
NP - Nepal 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
AU - Australia 6
EG - Egitto 6
KR - Corea 6
PH - Filippine 6
PY - Paraguay 6
SA - Arabia Saudita 6
UY - Uruguay 6
DK - Danimarca 5
ID - Indonesia 5
KE - Kenya 5
PT - Portogallo 5
AL - Albania 4
BO - Bolivia 4
CH - Svizzera 4
KZ - Kazakistan 4
PE - Perù 4
AZ - Azerbaigian 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
OM - Oman 3
PS - Palestinian Territory 3
RO - Romania 3
TN - Tunisia 3
AO - Angola 2
BH - Bahrain 2
CI - Costa d'Avorio 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
JM - Giamaica 2
LB - Libano 2
LU - Lussemburgo 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GN - Guinea 1
Totale 30.109
Città #
Milan 2.866
Fairfield 1.834
Ashburn 1.261
San Jose 1.151
Woodbridge 1.128
Jacksonville 1.102
Chandler 1.089
Singapore 943
Houston 842
Seattle 799
Wilmington 728
Ann Arbor 659
Cambridge 607
Hong Kong 539
Dearborn 394
Princeton 380
Dublin 355
Izmir 352
Nyköping 349
Dallas 286
The Dalles 269
Beijing 254
Rome 240
Boardman 224
Dong Ket 218
Como 192
Chicago 188
Lauterbourg 174
New York 173
San Mateo 162
Council Bluffs 117
Ho Chi Minh City 108
Los Angeles 92
San Diego 89
Hanoi 83
Santa Clara 77
Ogden 61
Helsinki 60
Washington 60
São Paulo 53
Tokyo 53
Hefei 51
London 50
Kunming 43
Mexico City 41
Munich 40
Orem 40
Guangzhou 39
Norwalk 39
Nanjing 35
Toronto 35
Warsaw 33
Brussels 30
Chennai 26
Varese 25
Brooklyn 24
Ponte Lambro 23
Brno 22
Montreal 22
Phoenix 22
Denver 19
Johannesburg 19
Nanchang 19
Verona 19
Atlanta 18
Mcallen 18
Redwood City 18
Frankfurt am Main 17
Kocaeli 17
Berlin 16
Da Nang 16
Düsseldorf 16
Jinan 16
Nuremberg 16
Ankara 15
Manchester 15
Stockholm 15
Cagliari 14
Fuzhou 14
Poplar 14
San Francisco 14
Shanghai 14
Falls Church 13
Amsterdam 12
Carbonara Al Ticino 12
Edinburgh 12
Naples 12
Kuala Lumpur 11
Mumbai 11
Shenzhen 11
Zhengzhou 11
Abuja 10
Boston 10
Hangzhou 10
Paris 10
Dhaka 9
Shenyang 9
Amman 8
Belo Horizonte 8
Chengdu 8
Totale 21.797
Nome #
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 318
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats 287
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect 286
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 282
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 276
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi 266
Assay of GTPγS binding in autoradiography 262
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2 261
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 260
Adolescent exposure to cannabis as a risk factor for psychiatric disorders 259
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine 251
A molecular basis of analgesic tolerance to cannabinoids 250
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 247
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour 241
MeCP2 related studies benefit from the use of CD1 as genetic background 238
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 237
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol. 233
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats. 232
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism 229
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats 225
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 223
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence. 218
New vistas on cannabis use disorder 218
Long lasting consequences of cannabis exposure in adolescence. 216
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling 214
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat 213
Endocannabinoids and Mental Disorders. 212
Cannabinoids and opioids share cAMP pathway in rat splenocytes 209
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine 209
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche 209
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. 206
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 204
Role of endocannabinoids in regulating drug dependence 203
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring 203
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor. 202
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. 199
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. 198
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT? 197
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 195
Expression and function of the endocannabinoid system in glial cells. 192
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain 192
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 192
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. 192
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw 191
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. 189
Sex-dependent vulnerability to cannabis abuse in adolescence 187
Cannabinoids and Drugs of abuse 186
Cellular mechanisms underlying the interaction between cannabinoid and opioid system 186
The endocannabinoid system and psychiatric disorders. 186
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 186
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. 185
Endocannabinoids and Drug Dependence 184
The endocannabinoid system and schizophrenia: integration of evidence. 181
Modulation of rat brain cannabinoid receptors after chronic morphine treatment 179
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain 177
Neurobiological mechanisms underlying cannabis-induced memory impairment 176
Endocannabinoids in the immune system and cancer 175
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940 175
Molecular and cellular basis of cannabinoid and opioid interactions 173
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats 173
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system 173
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects 171
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system 170
Cannabidiol inhibits angiogenesis by multiple mechanisms 169
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments 168
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade 168
The psychoactive ingredient of marijuana induces behavioural sensitization 166
A role of nitric oxide in WIN 55,212-2 tolerance in mice. 166
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure 165
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 163
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat 162
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems 162
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. 161
Alterazioni cellulari indotte da farmaci d'abuso e da stimoli avversivi non evitabili nel sistema nervoso centrale di ratto 161
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251. 161
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors 159
Cholera toxin effects on body temperature changes induced by morphine. 158
Uso di Cannabis in adolescenza come fattore di rischio per malattie psichiatriche e dipendenza da altre sostanze 158
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages 157
Presence and functional regulation of cannabinoid receptors in immune cells 157
Alterazioni cellulari e molecolari presenti nel sistema nervoso centrale durante i processi di sensitizzazione a lungo termine indotti da diversi farmaci d'abuso 156
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. 156
Binding studies of dermorphin and its L-form on rat brain opioid receptors. 156
Cannabinoids as potential new therapy for the treatment of gliomas. 154
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. 154
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats. 154
Inhibition of tumor cell migration 153
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system 152
Pertussis toxin inhibits the antinociceptive action of morphine in the rat.. 152
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats. 152
Antitumor effects of cannabidiol , a nonpsychoative cannabinoid, on Human glioma cell lines 151
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line 151
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization 149
Presence of a reduced opioid response in interleukin-6 knock out mice 149
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models 149
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat. 148
Ruolo emergente dei meccanismi epigenetici e della neuroinfiammazione nei disturbi associate al consume di cannabis 147
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors 146
Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. 146
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models 146
Totale 19.241
Categoria #
all - tutte 111.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021478 0 0 0 0 0 0 0 0 0 0 0 478
2021/20221.930 192 203 182 251 58 89 71 94 94 282 149 265
2022/20232.722 265 165 192 326 157 582 10 378 399 75 120 53
2023/20244.570 717 743 725 832 902 350 31 76 100 28 23 43
2024/20252.706 39 42 483 78 74 174 100 211 349 217 222 717
2025/20265.952 424 379 137 792 581 433 1.386 369 702 369 239 141
Totale 30.258